These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 22961677

  • 1. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
    Rungoe C, Basit S, Ranthe MF, Wohlfahrt J, Langholz E, Jess T.
    Gut; 2013 May; 62(5):689-94. PubMed ID: 22961677
    [Abstract] [Full Text] [Related]

  • 2. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN, Wajda A, Blanchard JF.
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
    [Abstract] [Full Text] [Related]

  • 3. Risk of Ischaemic Heart Disease in Patients with Inflammatory Bowel Disease: Cohort Study Using the General Practice Research Database.
    Close H, Mason JM, Wilson DW, Hungin AP, Jones R, Rubin G.
    PLoS One; 2015 Jan; 10(10):e0139745. PubMed ID: 26461954
    [Abstract] [Full Text] [Related]

  • 4. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T, Simonsen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M.
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS, Lewis JD, Beaugerie L, Tierney A, Brensinger CM, Gisbert JP, Loftus EV, Peyrin-Biroulet L, Blonski WC, Van Domselaar M, Chaparro M, Sandilya S, Bewtra M, Beigel F, Biancone L, Lichtenstein GR.
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [Abstract] [Full Text] [Related]

  • 9. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study.
    Kristensen SL, Lindhardsen J, Ahlehoff O, Erichsen R, Lamberts M, Khalid U, Torp-Pedersen C, Nielsen OH, Gislason GH, Hansen PR.
    Europace; 2014 Apr; 16(4):477-84. PubMed ID: 24108228
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
    Gradel KO, Nielsen HL, Schønheyder HC, Ejlertsen T, Kristensen B, Nielsen H.
    Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
    [Abstract] [Full Text] [Related]

  • 14. Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis.
    Faurschou M, Mellemkjaer L, Sorensen IJ, Svalgaard Thomsen B, Dreyer L, Baslund B.
    Arthritis Rheum; 2009 Apr; 60(4):1187-92. PubMed ID: 19333952
    [Abstract] [Full Text] [Related]

  • 15. Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study.
    Elmberg M, Hultcrantz R, Simard JF, Stål P, Pehrsson K, Askling J.
    J Intern Med; 2012 Jul; 272(1):45-54. PubMed ID: 22026548
    [Abstract] [Full Text] [Related]

  • 16. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease.
    Jess T, Simonsen J, Nielsen NM, Jørgensen KT, Bager P, Ethelberg S, Frisch M.
    Gut; 2011 Mar; 60(3):318-24. PubMed ID: 21193449
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
    Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L, Cesame Study Group.
    Gastroenterology; 2011 Nov; 141(5):1621-28.e1-5. PubMed ID: 21708105
    [Abstract] [Full Text] [Related]

  • 19. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
    Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE.
    Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
    [Abstract] [Full Text] [Related]

  • 20. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.
    Jess T, Horváth-Puhó E, Fallingborg J, Rasmussen HH, Jacobsen BA.
    Am J Gastroenterol; 2013 Dec; 108(12):1869-76. PubMed ID: 23978954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.